GKOS Completes Enrollment
Glaukos completes patient enrollment in Phase 2 study of GLK-321 for Demodex Blepharitis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Glaukos completes patient enrollment in Phase 2 study of GLK-321 for Demodex Blepharitis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.